Stocks of Palantir Technologies (PLTR 5.81%) are falling today despite gains for the broader market. November 9, 2025
MyMD Pharmaceuticals Enrolls First Client in Stage 2 Medical Trial of MYMD-1 as a Therapy for Delaying Aging and also Extending Healthy And Balanced Lifespan November 9, 2025
